Acute Myeloid Leukemia with Minimal Differentiation, also known as minimally differentiated acute myeloblastic leukemia, is related to acute myeloblastic leukemia without maturation and patau syndrome. An important gene associated with Acute Myeloid Leukemia with Minimal Differentiation is FLT3 (Fms Related Receptor Tyrosine Kinase 3), and among its related pathways/superpathways are NF-kappaB Signaling and Tyrosine Kinases / Adaptors. The drugs Fluconazole and Caspofungin have been mentioned in the context of this disorder. Affiliated tissues include myeloid and bone marrow, and related phenotypes are Increased shRNA abundance (Z-score > 2) and homeostasis/metabolism